However, no significant correlations were found between BRG1 expression and clinicopathologic variables that include patient age, tumor size, lymph node metastasis, histology grade, histology type, ER status, PR status and HER2 status (Table 1). Here, SMARCA4 is linked to metastatic malignant neoplasm in the lymph nodes.